Strong-arming immune regulation: Suppressing regulatory T-cell function to treat cancers

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In recent years there has been an accelerated understanding of immune regulatory mechanisms. Much of this immune regulation is linked to a collection of specialized regulatory cells of the T-cell lineage (Tregs). This collection consists of Tregs that are either thymically derived or peripherally induced. Tregs are important for controlling potentially autoreactive immune effectors and immune responses to foreign organisms and molecules. Their importance in maintaining immune homeostasis and the overall health of an organism cannot be overstated. However, there is a dark side, and Tregs may also be involved in the pathogenesis of malignancies. Evidence shows that tumors induce or recruit Tregs to block antitumor effectors. Thus, there are efforts underway to identify approaches that specifically inhibit the function of intratumoral Tregs, which could lead to increased immunity to tumors without off-target immune-related pathologies (i.e., autoimmune disease). In this review, the biology of Tregs is discussed along with their involvement in malignancies and emerging strategies to block their function.

Original languageEnglish (US)
Pages (from-to)379-389
Number of pages11
JournalFuture Oncology
Volume2
Issue number3
DOIs
StatePublished - Jun 2006

Fingerprint

Regulatory T-Lymphocytes
Neoplasms
Cell Lineage
Autoimmune Diseases
Immunity
Homeostasis
Pathology
T-Lymphocytes
Health

Keywords

  • Cancer
  • CD25
  • CTLA-4
  • Cyclophosphamide
  • Denileukin diftitox
  • Foxp3
  • Regulatory T cells
  • Tregs

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Strong-arming immune regulation : Suppressing regulatory T-cell function to treat cancers. / Knutson, Keith L.

In: Future Oncology, Vol. 2, No. 3, 06.2006, p. 379-389.

Research output: Contribution to journalArticle

@article{6d1878635ae841a5bec79a3e45c8ac9f,
title = "Strong-arming immune regulation: Suppressing regulatory T-cell function to treat cancers",
abstract = "In recent years there has been an accelerated understanding of immune regulatory mechanisms. Much of this immune regulation is linked to a collection of specialized regulatory cells of the T-cell lineage (Tregs). This collection consists of Tregs that are either thymically derived or peripherally induced. Tregs are important for controlling potentially autoreactive immune effectors and immune responses to foreign organisms and molecules. Their importance in maintaining immune homeostasis and the overall health of an organism cannot be overstated. However, there is a dark side, and Tregs may also be involved in the pathogenesis of malignancies. Evidence shows that tumors induce or recruit Tregs to block antitumor effectors. Thus, there are efforts underway to identify approaches that specifically inhibit the function of intratumoral Tregs, which could lead to increased immunity to tumors without off-target immune-related pathologies (i.e., autoimmune disease). In this review, the biology of Tregs is discussed along with their involvement in malignancies and emerging strategies to block their function.",
keywords = "Cancer, CD25, CTLA-4, Cyclophosphamide, Denileukin diftitox, Foxp3, Regulatory T cells, Tregs",
author = "Knutson, {Keith L}",
year = "2006",
month = "6",
doi = "10.2217/14796694.2.3.379",
language = "English (US)",
volume = "2",
pages = "379--389",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Strong-arming immune regulation

T2 - Suppressing regulatory T-cell function to treat cancers

AU - Knutson, Keith L

PY - 2006/6

Y1 - 2006/6

N2 - In recent years there has been an accelerated understanding of immune regulatory mechanisms. Much of this immune regulation is linked to a collection of specialized regulatory cells of the T-cell lineage (Tregs). This collection consists of Tregs that are either thymically derived or peripherally induced. Tregs are important for controlling potentially autoreactive immune effectors and immune responses to foreign organisms and molecules. Their importance in maintaining immune homeostasis and the overall health of an organism cannot be overstated. However, there is a dark side, and Tregs may also be involved in the pathogenesis of malignancies. Evidence shows that tumors induce or recruit Tregs to block antitumor effectors. Thus, there are efforts underway to identify approaches that specifically inhibit the function of intratumoral Tregs, which could lead to increased immunity to tumors without off-target immune-related pathologies (i.e., autoimmune disease). In this review, the biology of Tregs is discussed along with their involvement in malignancies and emerging strategies to block their function.

AB - In recent years there has been an accelerated understanding of immune regulatory mechanisms. Much of this immune regulation is linked to a collection of specialized regulatory cells of the T-cell lineage (Tregs). This collection consists of Tregs that are either thymically derived or peripherally induced. Tregs are important for controlling potentially autoreactive immune effectors and immune responses to foreign organisms and molecules. Their importance in maintaining immune homeostasis and the overall health of an organism cannot be overstated. However, there is a dark side, and Tregs may also be involved in the pathogenesis of malignancies. Evidence shows that tumors induce or recruit Tregs to block antitumor effectors. Thus, there are efforts underway to identify approaches that specifically inhibit the function of intratumoral Tregs, which could lead to increased immunity to tumors without off-target immune-related pathologies (i.e., autoimmune disease). In this review, the biology of Tregs is discussed along with their involvement in malignancies and emerging strategies to block their function.

KW - Cancer

KW - CD25

KW - CTLA-4

KW - Cyclophosphamide

KW - Denileukin diftitox

KW - Foxp3

KW - Regulatory T cells

KW - Tregs

UR - http://www.scopus.com/inward/record.url?scp=33745496582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745496582&partnerID=8YFLogxK

U2 - 10.2217/14796694.2.3.379

DO - 10.2217/14796694.2.3.379

M3 - Article

C2 - 16787118

AN - SCOPUS:33745496582

VL - 2

SP - 379

EP - 389

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 3

ER -